Soluble interleukin-2 receptor decrease in the sera of HIV-infected patients treated with zidovudine.

Soluble interleukin-2 receptor in sera of patients with Graves' disease.

Increased level of soluble interleukin-2 receptor in sera of patients with Graves' disease.

Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis.

Vitamin B12 injections in patients treated with zidovudine.

Recombinant human erythropoietin for patients with AIDS treated with zidovudine.

Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis.

Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.

Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer.

Interleukin-2, soluble interleukin-2 receptor and tumor necrosis factor in sera from patients with rheumatoid arthritis.

Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Soluble immunologic products in scleroderma sera.

Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab.

Chloramphenicol concentrations in sera of patients with typhoid fever being treated with oral or intravenous preparation.

Pigmented nail bands and mucocutaneous pigmentation in HIV-positive patients treated with zidovudine.

When should asymptomatic patients with HIV infection be treated with zidovudine?

Serum soluble interleukin-2 receptor in patients with glomerulonephritis.

Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy.

Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.

Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib.

Decrease in neuroimmune activation by HSV-mediated gene transfer of TNFα soluble receptor alleviates pain in rats with diabetic neuropathy.

Mechanism of action of maternal serum on the interleukin2 receptor expression.

Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.

Suggest Documents

Soluble interleukin-2 receptor in sera of patients with Graves' disease.

Increased level of soluble interleukin-2 receptor in sera of patients with Graves' disease.

Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis.

Vitamin B12 injections in patients treated with zidovudine.

Recombinant human erythropoietin for patients with AIDS treated with zidovudine.

Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis.

Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.

Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer.

Interleukin-2, soluble interleukin-2 receptor and tumor necrosis factor in sera from patients with rheumatoid arthritis.

Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Soluble immunologic products in scleroderma sera.

Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab.

Chloramphenicol concentrations in sera of patients with typhoid fever being treated with oral or intravenous preparation.

Pigmented nail bands and mucocutaneous pigmentation in HIV-positive patients treated with zidovudine.

When should asymptomatic patients with HIV infection be treated with zidovudine?

Serum soluble interleukin-2 receptor in patients with glomerulonephritis.

Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy.

Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.

Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib.

Decrease in neuroimmune activation by HSV-mediated gene transfer of TNFα soluble receptor alleviates pain in rats with diabetic neuropathy.

Mechanism of action of maternal serum on the interleukin2 receptor expression.

Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.

Soluble interleukin-2 receptor decrease in the sera of HIV-infected patients treated with zidovudine.

Recommend Documents

Follow Us